The international classification of retinopathy of prematurity revisited: An international committee for the classification of retinopathy of prematurity

Archives of Ophthalmology

Volumn 123, Issue 7, 2005, Pages 991-999

  Quinn, Graham E ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE CLASSIFICATION; DISEASE SEVERITY; HUMAN; MEDICAL LITERATURE; NEOVASCULARIZATION (PATHOLOGY); OPHTHALMOSCOPY; PRIORITY JOURNAL; REMISSION; RETINA DETACHMENT; RETINA DISEASE; RETROLENTAL FIBROPLASIA; REVIEW; CLASSIFICATION; CONFERENCE PAPER; CONSENSUS DEVELOPMENT; INTERNATIONAL CLASSIFICATION OF DISEASES; NEWBORN; PATHOLOGY; RETINA BLOOD VESSEL;

HUMANS; INFANT, NEWBORN; INTERNATIONAL CLASSIFICATION OF DISEASES; RETINAL VESSELS; RETINOPATHY OF PREMATURITY;

EID: 22844447612     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.123.7.991     Document Type: Review

References (16)

1. Committee for the Classification of Retinopathy of Prematurity. An International Classification of Retinopathy of Prematurity. Arch Ophthalmol. 1984;102:1130-1134.
2. ICROP Committee for Classification of Late Stages ROP. An international classification of retinopathy of prematurity, II: the classification of retinal detachment. Arch Ophthalmol. 1987;105:906-912.
3. Gallagher K, Moseley M, Tandon A, Watson MP, Cocker KD, Fielder AR. Asymmetric location of retinopathy of prematurity in the nasal and temporal retina. Arch Ophthalmol. 2003;121:1563-1568.
4. Cryotherapy for Retinopathy of Prematurity Cooperative Group. The natural ocular outcome of prematurebirthandretinopathy.ArchOphthalmol. 1994;112:903-912.
5. Palmer E, Flynn J, Hardy R, et al. Incidence and early course of retinopathy of prematurity. Ophthalmology. 1991;98:1628-1638.
6. Vander J, Handa J, McNamara A, et al. Early Treatment of posterior retinopathy of prematurity: a controlled trial. Ophthalmology. 1997;104:1731-1736.
7. The STOP-ROP Multicenter Study Group. Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP): a randomized, controlled trial, I: primary outcomes. Pediatrics. 2000;105:295-310.
8. The design of the multicenter study of light reduction in retinopathy of prematurity (LIGHT-ROP). J Pediatr Ophthalmol Strabismus. 1999;36:257-263.
9. Early Treatment for Retinopathy of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the Early Treatment for Retinopathy of Prematurity Randomized Trial. Arch Ophthalmol. 2003;121: 1684-1694.
10. Soejima N, Takagi I, Takashima Y. Clinical studies on retinopathy of prematurity, severe and rapidly progressive type. Folia Ophthalmol Jpn. 1976; 27:155-161.
11. Morizane H. Initial sign and clinical course of the most severe form of acute proliferative retrolental fibroplasia (type II) [in Japanese]. Nippon Ganka Gakkai Zasshi. 1976;80:54-61.
12. Uemura Y, Tsukahara I, Nagata M, et al. Diagnostic and therapeutic criteria for retinopathy of prematurity. Committee’s Report Appointed by the Japanese Ministry of Health and Welfare. Tokyo, Japan: Japanese Ministry of Health and Welfare; 1974.
13. Kushner B, Essner D, Cohen I, Flynn J. Retrolental fibroplasia, II: pathologic correlation. Arch Ophthalmol. 1977;95:29-38.
14. Katz X, Kychenthal A, Dorta P. Zone I retinopathy of prematurity. J AAPOS. 2000;4:373-376.
15. Repka MX, Palmer EA, Tung B; on behalf of the CRYO-ROP Cooperative Group. Involution of retinopathy of prematurity. Arch Ophthalmol. 2000; 118:645-649.
16. A classification of retrolental fibroplasia. Am J Ophthalmol. 1953;36:1333-1335.